RT Journal Article
SR Electronic
T1 Management of malaria in children under 5-years-old during COVID-19 pandemic in Sierra Leone: a lesson learned?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.04.20225714
DO 10.1101/2020.11.04.20225714
A1 Buonsenso, Danilo
A1 Iodice, Francesco
A1 Cinicola, Bianca
A1 Raffaelli, Francesca
A1 Sowa, Solia
A1 Ricciardi, Walter
YR 2020
UL http://medrxiv.org/content/early/2020/11/05/2020.11.04.20225714.abstract
AB Growing evidences are showing the potential indirect effects of COVID-19 on the health systems of low-resource settings, where diseases such as Tuberculosis, HIV and Malaria represent major killers. Therefore, we performed a retrospective study aimed to evaluate the impact of COVID-19 on Malaria programs in a peripheral region of Sierra Leone, previously involved by the Ebola outbreak in 2015, when malaria care have been impaired since local health systems were overwhelmed by Ebola cases. During COVID-19 in Sierra Leone, we did not notice a drop in malaria diagnosis in children, suggesting that a proactive approach in the management of malaria in endemic countries during COVID-19 may have had a positive impact. A comprehensive approach that include also educational activities to sensitize the local population, was useful to guarantee successful malaria diagnosis and treatment, and prevents excess of malaria deaths due to potential disruption of the local health systems related to the SARS-CoV-2 pandemic.Contribution to the field we performed a retrospective study aimed to evaluate the impact of COVID-19 on Malaria programs in a peripheral region of Sierra Leone, previously involved by the Ebola outbreak in 2015, when malaria care have been impaired since local health systems were overwhelmed by Ebola cases. During COVID-19 in Sierra Leone, we did not notice a significant change in the middle term period in malaria diagnosis in children, suggesting that a proactive approach in the management of malaria in endemic countries during COVID-19 may have had a positive impact. A comprehensive approach that include also educational activities to sensitize the local population, was useful to guarantee successful malaria diagnosis and treatment, and prevents excess of malaria deaths due to potential disruption of the local health systems related to the SARS-CoV-2 pandemic.Funding statement nothing to declareStudies involving animal subjects Generated Statement: No animal studies are presented in this manuscript.Studies involving human subjects Generated Statement: The studies involving human participants were reviewed and approved by Bureh Town Community Hospital. Written informed consent to participate in this study was provided by the participants’ legal guardian/next of kin.Inclusion of identifiable human data Generated Statement: No potentially identifiable human images or data is presented in this study.Data availability statement Generated Statement: The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementnothingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by a local commission composed of the responsible of the Malaria unit of the local health centre (S.S.), the research team of the Bureh Town Community Hospital of Sierra Leone, the headman of the community and the old men of the village, in a similar way to what happens for all the important political and economic decisions in the examined area (n25_may-2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesavailable upon request